There have been reported that MMP9 is not only associated with the severity and mortality of COVID-19 but also with venous thromboembolism, chronic myocardial fibrosis, and susceptibility to COVID-19-related neurologic syndrome (36–40). Here, MMP9 is linked to venous thromboembolism.